136 related articles for article (PubMed ID: 11464449)
21. Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolemic subjects.
Puccetti L; Bruni F; Bova G; Cercignani M; Palazzuoli A; Console E; Auteri A; Pasqui AL
Nutr Metab Cardiovasc Dis; 2001 Dec; 11(6):378-87. PubMed ID: 12055702
[TBL] [Abstract][Full Text] [Related]
22. Assessment of the efficacy of different statins in murine collagen-induced arthritis.
Palmer G; Chobaz V; Talabot-Ayer D; Taylor S; So A; Gabay C; Busso N
Arthritis Rheum; 2004 Dec; 50(12):4051-9. PubMed ID: 15593180
[TBL] [Abstract][Full Text] [Related]
23. Long-term effects of statins on arterial pressure and stiffness of hypertensives.
Ichihara A; Hayashi M; Koura Y; Tada Y; Kaneshiro Y; Saruta T
J Hum Hypertens; 2005 Feb; 19(2):103-9. PubMed ID: 15361892
[TBL] [Abstract][Full Text] [Related]
24. [Coronary disease prevention: only the inhibition of inflammation is important. Why lower lipids, too?].
Sudhop T; von Bergmann K
MMW Fortschr Med; 2003 May; 145(21):19. PubMed ID: 12845862
[No Abstract] [Full Text] [Related]
25. Lipid treatment goals achieved in patients treated with statin drugs in Norwegian general practice.
Svilaas A; Risberg K; Thoresen M; Ose L
Am J Cardiol; 2000 Dec; 86(11):1250-3, A6. PubMed ID: 11090801
[TBL] [Abstract][Full Text] [Related]
26. [Statins: similarities and differences in the pharmacological, clinical and laboratory aspects].
Motti C; Gnasso A; Cortese C
Ann Ital Med Int; 2000; 15(1):96-102. PubMed ID: 10842898
[TBL] [Abstract][Full Text] [Related]
27. Persistence and adherence to cholesterol lowering agents: evidence from Régie de l'Assurance Maladie du Québec data.
Lachaine J; Rinfret S; Merikle EP; Tarride JE
Am Heart J; 2006 Jul; 152(1):164-9. PubMed ID: 16824851
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of atorvastatin and simvastatin for treatment of multiple sclerosis.
Neuhaus O; Hartung HP
Expert Rev Neurother; 2007 May; 7(5):547-56. PubMed ID: 17492904
[TBL] [Abstract][Full Text] [Related]
29. Anti-atherosclerotic effects of statins: lessons from prevention trials.
Ganesh SK; Nass CM; Blumenthal RS
J Cardiovasc Risk; 2003 Jun; 10(3):155-9. PubMed ID: 12775947
[TBL] [Abstract][Full Text] [Related]
30. Torcetrapib/atorvastatin combination therapy.
Bays H; McKenney J; Davidson M
Expert Rev Cardiovasc Ther; 2005 Sep; 3(5):789-820. PubMed ID: 16181026
[TBL] [Abstract][Full Text] [Related]
31. Safety of high-dose atorvastatin therapy.
Waters DD
Am J Cardiol; 2005 Sep; 96(5A):69F-75F. PubMed ID: 16126026
[TBL] [Abstract][Full Text] [Related]
32. Clash of the statins? A trial pitting two popular statins against each other helps answer a far more important question: how low should cholesterol go?
Harv Heart Lett; 2004 Feb; 14(6):5. PubMed ID: 14980886
[No Abstract] [Full Text] [Related]
33. Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials?
Ray KK; Cannon CP; Ganz P
Am J Cardiol; 2006 Dec; 98(11A):18P-25P. PubMed ID: 17126675
[TBL] [Abstract][Full Text] [Related]
34. [Atherosclerosis and simvastatin: new questions for the new millennium].
Tubaro M; Guido V; Sciarra L; Mustilli M; Carbone MA; D'Errico F
Ann Ital Med Int; 2000; 15(1):108-14. PubMed ID: 10842900
[TBL] [Abstract][Full Text] [Related]
35. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.
Mills EJ; Rachlis B; Wu P; Devereaux PJ; Arora P; Perri D
J Am Coll Cardiol; 2008 Nov; 52(22):1769-81. PubMed ID: 19022156
[TBL] [Abstract][Full Text] [Related]
36. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients.
John S; Schneider MP; Delles C; Jacobi J; Schmieder RE
Am Heart J; 2005 Mar; 149(3):473. PubMed ID: 15864218
[TBL] [Abstract][Full Text] [Related]
37. Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia.
Milionis HJ; Kakafika AI; Tsouli SG; Athyros VG; Bairaktari ET; Seferiadis KI; Elisaf MS
Am Heart J; 2004 Oct; 148(4):635-40. PubMed ID: 15459594
[TBL] [Abstract][Full Text] [Related]
38. Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial.
Nissen SE
Am J Cardiol; 2005 Sep; 96(5A):61F-68F. PubMed ID: 16126025
[TBL] [Abstract][Full Text] [Related]
39. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
Mendoza S; Gamez R; Mas R; Goicochea E
Int J Tissue React; 2003; 25(3):81-9. PubMed ID: 14756189
[TBL] [Abstract][Full Text] [Related]
40. [The hyperlipidemias. Role of various statins].
Farnier M
Presse Med; 1999 Nov; 28(36):2002-10. PubMed ID: 10599269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
